医薬品販売受託市場レポート：2023-2033
Pharma Contract Sales Market Report 2023-2033
レポート詳細
医薬品販売受託市場レポート 2023-2033年 ： 本レポートは、業界とその基礎となる原動力をより良く理解することを望むなら、新たな収益ポケットを目指す大手企業にとって貴重なものとな... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
医薬品販売受託市場レポート 2023-2033年： 本レポートは、業界とその基礎となる原動力をより良く理解することを望むなら、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。異業種への進出や新規地域での既存事業の拡大を目指す企業にとっても有用なレポートです。
CROとCSOを統合し、エンド・ツー・エンドのサービスを提供するグローバル企業
業界の大手企業は、医薬品開発業務受託機関（CRO）と医薬品販売業務受託機関（CSO）の業務を統合し、大きな利益をもたらしている。いくつかの著名なCROプロバイダーは、M&A（合併・買収）を通じて、自社のサービスと商業化能力を効果的に統合し、医薬品開発の道のり全体にわたって顧客に包括的なソリューションを提供できるようにしている。
このような戦略的な動きの顕著な例としては、INCリサーチの買収とその後のシネオスへのブランド変更、クインタイルズによるIMSの買収などがある。同様に、2023年1月、ピュブリシス・グループは、ブルガリアの著名なパフォーマンス・マーケティング・エージェンシーであるアドバタイズBGの買収を明らかにした。この戦略的な動きは、デジタル戦略、データ分析、ソーシャルメディア管理、デジタルコンテンツ制作のサービスを強化し、デジタル変革におけるピュブリシス・グループ・ブルガリアの能力を高めることを目的としている。
CROとCSOの業界では、このような統合と統合の動きが進んでおり、販売受託サービスの需要が高まると予想される。研究、開発、商品化サービスのシームレスな統合は、医薬品開発プロセスの合理化と効率化を促進する。全体的かつ効率的なアプローチを求める顧客は、エンド・ツー・エンドのソリューションを提供するプロバイダーにますます目を向けるようになり、販売受託サービスの需要をさらに刺激するものと思われる。
医薬品販売受託サービスへの需要の高まり
近年、製薬業界は多様化と専門化によって大きな変貌を遂げている。この進化により、医薬品販売受託サービスに対する需要が世界中で高まっています。製薬会社が製品ポートフォリオを拡大し、より広範な治療領域を網羅するにつれ、これらの多様な製品を効果的に宣伝・販売するという課題に直面しています。
医薬品販売受託サービスは、専門的な営業チームとオーダーメイドのマーケティング戦略を提供することで、戦略的なソリューションを提供します。これらのサービスにより、製薬会社は深い業界知識とネットワークを持つ経験豊富な専門家にアクセスすることができ、多様な製品ラインの効率的な市場浸透が可能になります。さらに、販売受託サービスが提供する費用対効果と柔軟性は、リソース配分の最適化を目指す企業にとって魅力的な選択肢となります。
さらに、グローバル化によって市場範囲が拡大し、企業はさまざまな規制環境や市場力学に適応する必要があります。医薬品販売受託サービスは、各地域の市場に関する専門知識と理解を提供し、コンプライアンスと医療従事者との効果的な関わりを確保することで、この適応を促進します。
結論として、製薬業界の多様化により、機敏で専門的な営業・マーケティング手法の必要性が高まっている。医薬品販売受託サービスは、このような進化する需要に応えるための重要なツールとして登場し、最終的には医薬品業界が多様な市場に効果的にアプローチし、サービスを提供する能力を高めている。
市場調査レポートを購入する前にすべき質問とは？
- 医薬品販売受託市場はどのように進化しているのか？
- 医薬品販売受託市場の推進要因と阻害要因は何か？
- 医薬品販売受託の各サブ市場セグメントは予測期間中にどのように成長し、2033年にはどれくらいの売上高を占めるようになるのか？
- 2023年から2033年にかけて、医薬品販売受託の各サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて市場全体を牽引する主な要因は何か？
- 医薬品販売受託の主要市場はマクロ経済の動きに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどう変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しは？
- これらの大手企業の医薬品販売受託プロジェクトは？
- 2023年から2033年の間に、業界はどのように発展するのか？現在および今後10年間に実施される医薬品販売受託プロジェクトにはどのような意味があるのか？
- 医薬品販売受託市場をさらに拡大するために、製品の商業化の必要性は高まっているか？
- 医薬品販売受託市場はどこへ向かい、どのようにすれば市場の最前線に立てるか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？
このことが、現在、そして今後10年間の医薬品販売受託市場にどのような影響を与えるかを見極める必要がある：
- 304ページにわたる本レポートでは、128の表と172の図表を掲載しています。
- 本レポートは、業界における主要な有利分野にハイライトを当てているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
本レポートは、医薬品販売受託市場が今後10年間にどのように発展するか、またCOVID-19の景気後退と好転の変動に合わせてどのように発展するかをお伝えします。この市場は過去10年間のどの時点よりも今が重要です。
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題を含む）、コスト構造、医薬品販売受託価格上昇の影響、最近の動向をご覧いただけます。
本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。
レポート対象セグメント
タイプ
- 個人プロモーション
- 販売促進チーム
- 欠員管理
- ヘルスケアプロフェッショナル
- 非個人的プロモーション
- コンタクトセンター
- テレディテーリング
- 医療コールセンター
- テレサンプリング
- オンラインサービス
- 共同プロモーション
- マーケティングリサーチとコンサルティング
- 製品商業化
- テリトリーの最適化と調整
- ブランド・マネジメント
- 成熟製品ラインのサポート
- その他のCSOサービス
治療薬
- 腫瘍学
- 免疫学
- 糖尿病
- 心血管疾患
- 呼吸器
- 中枢神経系
- その他
世界市場全体と各分野の売上予測に加え、5つの地域と21の主要国市場の売上予測も掲載しています：
北米
- アメリカ
- カナダ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- ロシア
- その他の欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ
MEA
- GCC
- 南アフリカ
- その他のMEA
本レポートでは、医薬品販売受託市場の2023年から2033年にかけての主要企業のプロファイルも掲載している。
報告書に掲載されている主要企業
・ Amplity Health
・ Apodi
・ CMIC HOLDINGS Co., Ltd.
・ Granard Pharmaceutical Sales ＆ Marketing
・ GTS Solution
・ ICON plc
・ Inizio Group Limited
・ IQVIA Inc.
・ MaBiCo
・ Marvecs GmbH
・ ONCALL, LLC
・ PUBLICIS GROUPE
・ QFR Solution
・ Sales Partnerships, Inc.
・ SOFIP
・ Syneos Health
・ Uniphar Group Plc
・ Vanguard Pharma
医薬品販売受託市場全体の世界売上高、2023年～2033年、金額ベースでは2023年に76億米ドルを突破するとの試算を発表。2033年まで力強い収益成長を予測。当調査では、最も大きな可能性を秘めた企業を特定しています。各社の能力、進捗状況、商業的見通しを把握し、一歩先を行くための一助としてください。
医薬品販売受託市場、2023-2033年レポートが貴社のお役に立つか？
要約すると、300ページ以上に及ぶ本レポートは以下の知識を提供します：
まとめると、300ページを超えるこのレポートは、以下のような知識を提供する：
- 医薬品販売受託市場の2023年から2033年までの収益予測 世界および地域レベルでのタイプ別予測と治療法別予測 - 業界の展望を発見し、投資と収益に最も有利な場所を見つけます。
- 5つの地域と21の主要国市場の2033年までの収益予測 - 北米、欧州、アジア太平洋、ラテンアメリカ、MEAの医薬品販売受託市場2023年から2033年までの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要国の市場も予測しています。
- 既存企業や市場参入を目指す企業の展望 - 医薬品販売受託市場に関わる主要企業18社の企業プロファイルを含む、2023年から2033年までの市場。
独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。Visiongainのレポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、医薬品販売受託市場、2023年から2033年、市場をリードする企業の商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1 レポート概要
1.1 研究の目的
1.2 医薬品販売受託市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートの対象者
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて
2 エグゼクティブ・サマリー
3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場牽引要因
3.2.1.1 製薬業界におけるデータの重要性の高まりが市場需要を牽引
3.2.1.2 エンド・ツー・エンドのサービスを提供するためにCROとCSOを統合するグローバル企業
3.2.1.3 医薬品販売の変革：医薬品サービス業界におけるテクノロジーとアウトソーシング
3.2.2 市場阻害要因
3.2.2.1 競争の激しい医薬品受託サービス市場における品質の課題
3.2.2.2 医薬品受託製造における規制上のハードルとタイムラインへの対応
3.2.3 市場機会
3.2.3.1 アジア市場における医薬品拡大の機会の増加
3.2.3.2 製薬業界の多様化傾向：市場機会を創出する無機的・有機的活動の増加
3.3 COVID-19の影響分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力
3.4.2 買い手の交渉力
3.4.3 競争相手のライバル関係
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析
4 医薬品販売受託市場分析タイプ別
4.1 主要な調査結果
4.2 タイプ別セグメント 市場魅力度指数
4.3 医薬品販売受託のタイプ別市場規模推定と予測
4.4 パーソナルプロモーション
4.4.1 2023〜2033年の地域別市場規模（US$ Million）
4.4.2 地域別市場シェア、2023年・2033年 (%)
4.4.3 プロモーション営業チーム
4.4.3.1 2023～2033年の地域別市場規模（US$ Million）
4.4.3.2 地域別市場シェア、2023年・2033年 (%)
4.4.4 欠員管理
4.4.4.1 2023～2033年の地域別市場規模（US$ Million）
4.4.4.2 地域別市場シェア、2023年・2033年 (%)
4.4.5 医療従事者
4.4.5.1 2023〜2033年の地域別市場規模（US$ Million）
4.4.5.2 地域別市場シェア、2023年・2033年 (%)
4.5 非パーソナルプロモーション
4.5.1 2023～2033年の地域別市場規模（US$ Million）
4.5.2 地域別市場シェア、2023年・2033年 (%)
4.5.3 コンタクトセンター
4.5.3.1 2023年～2033年の地域別市場規模（US$ Million）
4.5.3.2 地域別市場シェア、2023年・2033年 (%)
4.5.4 遠隔ディテーリング
4.5.4.1 2023～2033年の地域別市場規模（US$ Million）
4.5.4.2地域別市場シェア、2023年・2033年 (%)
4.5.5 医療コールセンター
4.5.5.1 2023～2033年の地域別市場規模（US$ Million）
4.5.5.2 地域別市場シェア、2023年・2033年 (%)
4.5.6 テレサンプリング
4.5.6.1 2023～2033年の地域別市場規模（US$ Million）
4.5.6.2 地域別市場シェア、2023年・2033年 (%)
4.5.7 オンラインサービス
4.5.7.1 2023年～2033年の地域別市場規模（US$ Million）
4.5.7.2 地域別市場シェア、2023年・2033年 (%)
4.6 共同販促
4.6.1 2023～2033年の地域別市場規模（US$ Million）
4.6.2 地域別市場シェア、2023年・2033年(%)
4.6.3 マーケティングリサーチとコンサルティング
4.6.3.1 2023～2033年の地域別市場規模（US$ Million）
4.6.3.2 地域別市場シェア、2023年・2033年 (%)
4.6.4 製品の商業化
4.6.4.1 2023〜2033年の地域別市場規模（US$ Million）
4.6.4.2 地域別市場シェア、2023年・2033年 (%)
4.6.5 テリトリーの最適化と調整
4.6.5.1 2023～2033年の地域別市場規模（US$ Million）
4.6.5.2 地域別市場シェア、2023年・2033年 (%)
4.6.6 ブランドマネジメント
4.6.6.1 2023〜2033年の地域別市場規模（US$ Million）
4.6.6.2 地域別市場シェア、2023年・2033年 (%)
4.6.7 成熟した製品ラインサポート
4.6.7.1 2023～2033年の地域別市場規模（US$ Million）
4.6.7.2 地域別市場シェア、2023年・2033年 (%)
4.6.8 その他のすべてのCSOサービス
4.6.8.1 2023～2033年の地域別市場規模（US$ Million）
4.6.8.2 地域別市場シェア、2023年・2033年 (%)
5 医薬品販売受託市場分析：治療薬別
5.1 主な調査結果
5.2 治療薬セグメント 市場魅力度指数
5.3 治療薬別医薬品販売受託市場規模の推定と予測
5.4 がん領域
5.4.1 2023〜2033年の地域別市場規模（US$ Million）
5.4.2 地域別市場シェア、2023年・2033年(%)
5.5 免疫学
5.5.1 2023〜2033年の地域別市場規模（US$ Million）
5.5.2 地域別市場シェア、2023年・2033年(%)
5.6 糖尿病
5.6.1 2023〜2033年の地域別市場規模（US$ Million）
5.6.2 地域別市場シェア、2023年・2033年(%)
5.7 循環器疾患
5.7.1 2023〜2033年の地域別市場規模（US$ Million）
5.7.2 地域別市場シェア、2023年・2033年(%)
5.8 呼吸器
5.8.1 2023〜2033年の地域別市場規模（US$ Million）
5.8.2 地域別市場シェア、2023年・2033年(%)
5.9 中枢神経系
5.9.1 2023～2033年の地域別市場規模（US$ Million）
5.9.2 地域別市場シェア、2023年・2033年(%)
5.10 その他
5.10.1 2023〜2033年の地域別市場規模（US$ Million）
5.10.2 地域別市場シェア、2023年・2033年(%)
6 医薬品販売受託市場分析：地域別
6.1 主要な調査結果
6.2 地域別市場規模の推定と予測
7 北米の医薬品販売受託市場分析
7.1 主要な調査結果
7.2 北米医薬品販売受託市場魅力度指数
7.3 北米の医薬品受託販売国別市場、2023年、2028年、2033年（US$ Million）
7.4 北米の医薬品販売受託市場規模推定と予測：国別
7.5 北米の医薬品販売受託市場規模推定と予測：タイプ別
7.5.1 北米の医薬品販売受託市場規模推定と予測：パーソナルプロモーション別
7.5.2 北米の医薬品販売受託市場規模推定と予測：非個人プロモーション別
7.5.3 北米の医薬品販売受託市場規模推定と予測：共同プロモーション別
7.6 北米の医薬品販売受託市場規模推定と予測：治療薬別
7.7 米国の医薬品販売受託市場分析
7.8 カナダの医薬品販売受託市場分析
8 欧州の医薬品販売受託市場分析
8.1 主要な調査結果
8.2 欧州の医薬品販売受託市場魅力度指数
8.3 欧州の医薬品受託販売国別市場、2023年、2028年、2033年（US$ Million）
8.4 欧州の医薬品販売受託市場規模推定と予測：国別
8.5 欧州の医薬品販売受託市場規模推定と予測：タイプ別
8.5.1 欧州の医薬品販売受託市場規模推定と予測：パーソナルプロモーション別
8.5.2 欧州の医薬品販売受託市場規模推定と予測：非パーソナルプロモーション別
8.5.3 欧州の医薬品販売受託市場規模推定と予測：共同プロモーション別
8.6 欧州の医薬品販売受託市場規模推定と予測：治療薬別
8.7 ドイツの医薬品販売受託市場分析
8.8 フランスの医薬品販売受託市場分析
8.9 イギリスの医薬品販売受託市場の分析
8.10 イタリアの医薬品販売受託市場の分析
8.11 スペインの医薬品販売受託市場の分析
8.12 ロシアの医薬品販売受託市場の分析
8.13 その他の欧州の医薬品販売受託市場の分析
9 アジア太平洋の医薬品販売受託市場分析
9.1 主要な調査結果
9.2 アジア太平洋医薬品販売受託市場魅力度指数
9.3 アジア太平洋地域の医薬品受託販売国別市場、2023年、2028年、2033年（US$ Million）
9.4 アジア太平洋地域の医薬品販売受託市場規模推定と予測：国別
9.5 アジア太平洋地域の医薬品販売受託市場規模推定と予測：タイプ別予
9.5.1 アジア太平洋地域の医薬品販売受託市場規模推定と予測：パーソナルプロモーション別
9.5.2 アジア太平洋地域の医薬品受託販売市場規模推定と予測：非パーソナルプロモーション別
9.5.3 アジア太平洋地域の医薬品販売受託市場規模推定と予測：共同プロモーション別
9.6 アジア太平洋地域の医薬品販売受託市場規模推定と予測：治療薬別
9.7 日本の医薬品販売受託市場分析
9.8 中国の医薬品販売受託市場分析
9.9 インドの医薬品販売受託市場分析
9.10 オーストラリアの医薬品販売受託市場分析
9.11 韓国の医薬品販売受託市場分析
9.12 その他のアジア太平洋地域の医薬品販売受託市場分析
10 ラテンアメリカの医薬品販売受託市場分析
10.1 主要な調査結果
10.2 ラテンアメリカ医薬品販売受託市場魅力度指数
10.3 ラテンアメリカの医薬品受託販売国別市場、2023年、2028年、2033年 (US$ Million)
10.4 ラテンアメリカの医薬品販売受託市場規模推定と予測：国別
10.5 ラテンアメリカの医薬品販売受託市場規模推定と予測：タイプ別
10.5.1 ラテンアメリカの医薬品販売受託市場規模推定と予測：パーソナルプロモーション別
10.5.2 ラテンアメリカの医薬品受託販売市場規模推定と予測：非個人プロモーション別
10.5.3 ラテンアメリカの医薬品販売受託市場規模推定と予測：共同プロモーション別
10.6 ラテンアメリカの医薬品販売受託市場規模推定と予測：治療薬別
10.7 ブラジルの医薬品販売受託市場分析
10.8 メキシコの医薬品販売受託市場分析
10.9 その他のラテンアメリカの医薬品販売受託市場分析
11 MEAの医薬品販売受託市場分析
11.1 主要な調査結果
11.2 MEAの医薬品販売受託市場魅力度指数
11.3 MEAの医薬品受託販売国別市場、2023年、2028年、2033年（US$ Million）
11.4 MEAの医薬品販売受託市場規模推定と予測：国別
11.5 MEAの医薬品販売受託市場規模推定と予測：タイプ別
11.5.1 MEAの医薬品販売受託市場規模定と予測：パーソナルプロモーション別
11.5.2 MEAの医薬品受託販売市場規模推定と予測：非個人プロモーション別
11.5.3 MEAの医薬品販売受託市場規模推定と予測：共同プロモーション別
11.6 MEAの医薬品販売受託の市場規模推定と予測：治療薬別
11.7 GCCの医薬品販売受託市場分析
11.8 南アフリカの医薬品販売受託市場分析
11.9 その他のMEAの医薬品販売受託市場分析
12 企業のプロフィール
12.1 競争環境、2022年
12.2 戦略的展望
12.3 CMIC HOLDINGS Co., LTD.
12.3.1 会社概要
12.3.2 会社概要
12.3.3 財務分析
12.3.3.1 純収入、2017-2022年
12.3.4 ソリューション・ベンチマーキング
12.3.5 戦略的展望
12.4 IQVIA Inc.
12.4.1 会社概要
12.4.2 会社概要
12.4.3 財務分析
12.4.3.1 純収入、2017-2022年
12.4.3.2 地域市場シェア、2022年
12.4.4 ソリューションベンチマーキング
12.4.5 戦略的展望
12.5 Syneos Health
12.5.1 会社概要
12.5.2 会社概要
12.5.3 財務分析
12.5.3.1 純収入、2017-2022年
12.5.3.2 地域市場シェア、2022年
12.5.4 ソリューションベンチマーキング
12.5.5 戦略的展望
12.6 Inizio Group Limited
12.6.1 会社概要
12.6.2 会社概要
12.6.3 財務分析
12.6.3.1 純収入、2017-2022年
12.6.3.2 地域市場シェア、2022年
12.6.4 ソリューションベンチマーキング
12.6.5 戦略的展望
12.7 Uniphar Group Plc
12.7.1 会社概要
12.7.2 会社概要
12.7.3 財務分析
12.7.3.1 純収入、2017-2022年
12.7.4 ソリューションベンチマーキング
12.7.5 戦略的展望
12.8 ICON plc
12.8.1 会社概要
12.8.2 会社概要
12.8.3 財務分析
12.8.3.1 純収入、2017-2022年
12.8.3.2 地域市場シェア、2022年
12.8.4 ソリューションベンチマーキング
12.9 Amplity Health
12.9.1 会社概要
12.9.2 会社概要
12.9.3 ソリューションベンチマーキング
12.9.4 戦略的展望
12.10 Apodi
12.10.1 会社概要
12.10.2 会社概要
12.10.3 ソリューションベンチマーキング
12.11 Marvecs GmbH
12.11.1 会社概要
12.11.2 会社概要
12.11.3 ソリューションベンチマーキング
12.11.4 戦略的展望
12.12 ONCALL, LLC.
12.12.1 会社概要
12.12.2 会社概要
12.12.3 ソリューション・ベンチマーキング
12.13 PUBLICIS GROUPE
12.13.1 会社概要
12.13.2 会社概要
12.13.3 財務分析
12.13.3.1 純収入、2017年～2022年
12.13.3.2 地域市場シェア、2022年
12.13.4 ソリューションベンチマーキング
12.13.5 戦略的展望
12.14 SOFIP
12.14.1 会社概要
12.14.2 会社概要
12.14.3 ソリューション・ベンチマーキング
12.15 Granard Pharmaceutical Sales & Marketing
12.15.1 会社概要
12.15.2 会社概要
12.15.3 ソリューション・ベンチマーキング
12.16 Vanguard Pharma
12.16.1 会社概要
12.16.2 会社概要
12.16.3 ソリューション・ベンチマーキング
12.17 GTS Solution
12.17.1 会社概要
12.17.2 会社概要
12.17.3 ソリューション・ベンチマーキング
12.18 MaBiCo
12.18.1 会社概要
12.18.2 会社概要
12.18.3 ソリューション・ベンチマーキング
12.19 Sales Partnerships, Inc.
12.19.1 会社概要
12.19.2 会社概要
12.19.3 ソリューション・ベンチマーキング
12.20 QFR Solution
12.20.1 会社概要
12.20.2 会社概要
12.20.3 ソリューション・ベンチマーキング
13 結論と提言
13.1 Visiongainからの結びの言葉
13.2 市場プレイヤーへの提言
ページTOPに戻る
図表リスト
表の一覧
Table 1 Pharma Contract Sales Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Promotional Sales Team Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Vacancy Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Health Care Professional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Non-personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Contact Centre Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Tele-detailing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Medical Call Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Telesampling Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Online Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Co-promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Marketing Research and Consulting Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Product Commercialization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Territory Optimization & Alignment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Brand Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Mature Product Line Support Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Rest All CSO Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 25 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Diabetes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 CNS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 North America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 North America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 North America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 North America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 North America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 38 North America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 39 U.S. Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Canada Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Europe Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 42 Europe Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Europe Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Europe Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Europe Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 46 Europe Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 47 Germany Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 France Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 UK Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Italy Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Spain Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Russia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Rest of Europe Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Asia Pacific Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Asia Pacific Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Asia Pacific Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Asia Pacific Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Asia Pacific Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 59 Asia Pacific Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 60 Japan Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 China Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 India Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Australia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 South Korea Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Rest of Asia Pacific Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Latin America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Latin America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Latin America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 Latin America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 Latin America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 71 Latin America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 72 Brazil Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 Mexico Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Rest of Latin America Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 MEA Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 MEA Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 MEA Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 78 MEA Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 79 MEA Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 80 MEA Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 81 GCC Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 82 South Africa Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 83 Rest of MEA Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 84 Strategic Outlook
Table 85 CMIC HOLDINGS Co., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 CMIC Holdings Co., Ltd.: Solution Benchmarking
Table 87 CMIC Holdings Co., Ltd.: Strategic Outlook
Table 88 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 IQVIA Inc.: Solution Benchmarking
Table 90 IQVIA Inc.: Strategic Outlook
Table 91 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Syneos Health: Solution Benchmarking
Table 93 Syneos Health: Strategic Outlook
Table 94 Inizio Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Inizio Group Limited: Solution Benchmarking
Table 96 Inizio Group Limited: Strategic Outlook
Table 97 Uniphar Group Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Uniphar Group Plc: Solution Benchmarking
Table 99 Uniphar Group Plc: Strategic Outlook
Table 100 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 ICON plc: Solution Benchmarking
Table 102 Amplity Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Amplity Health: Solution Benchmarking
Table 104 Amplity Health: Strategic Outlook
Table 105 Apodi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Apodi: Solution Benchmarking
Table 107 Marvecs GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Marvecs GmbH: Solution Benchmarking
Table 109 Marvecs GmbH: Strategic Outlook
Table 110 ONCALL, LLC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 ONCALL, LLC.: Solution Benchmarking
Table 112 PUBLICIS GROUPE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 PUBLICIS GROUPE: Solution Benchmarking
Table 114 PUBLICIS GROUPE: Strategic Outlook
Table 115 SOFIP: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 SOFIP: Solution Benchmarking
Table 117 Granard Pharmaceutical Sales & Marketing: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Granard Pharmaceutical Sales & Marketing: Solution Benchmarking
Table 119 Vanguard Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Vanguard Pharma: Solution Benchmarking
Table 121 GTS Solution: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 GTS Solution: Solution Benchmarking
Table 123 MaBiCo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 MaBiCo: Solution Benchmarking
Table 125 Sales Partnerships, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Sales Partnerships, Inc.: Solution Benchmarking
Table 127 QFR Solution: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 QFR Solution: Solution Benchmarking
図の一覧
Figure 1 Pharma Contract Sales Market Segmentation
Figure 2 Pharma Contract Sales Market by Type: Market Attractiveness Index
Figure 3 Pharma Contract Sales Market by Therapeutics: Market Attractiveness Index
Figure 4 Pharma Contract Sales Market Attractiveness Index by Region
Figure 5 Pharma Contract Sales Market: Market Dynamics
Figure 6 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 7 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 8 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 9 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 10 Pharma Contract Sales Market: Porter’s Five Forces Analysis
Figure 11 Pharma Contract Sales Market: PEST Analysis
Figure 12 Pharma Contract Sales Market by Type: Market Attractiveness Index
Figure 13 Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 14 Pharma Contract Sales Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 15 Personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 16 Personal Promotion Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Promotional Sales Team Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Promotional Sales Team Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Vacancy Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Vacancy Management Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Health Care Professional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 22 Health Care Professional Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Non-personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Non-personal Promotion Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Contact Centre Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Contact Centre Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Tele-detailing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Tele-detailing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Medical Call Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 30 Medical Call Centres Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Telesampling Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 32 Telesampling Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Online Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 34 Online Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Co-promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 36 Co-promotion Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Marketing Research and Consulting Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Marketing Research and Consulting Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Product Commercialization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Product Commercialization Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Territory Optimization & Alignment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Territory Optimization & Alignment Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Brand Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Brand Management Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Mature Product Line Support Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Mature Product Line Support Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Rest All CSO Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Rest All CSO Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Pharma Contract Sales Market by Therapeutics: Market Attractiveness Index
Figure 50 Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 51 Pharma Contract Sales Market Share Forecast by Therapeutics, 2023, 2028, 2033 (%)
Figure 52 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 53 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 55 Immunology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Diabetes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 57 Diabetes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 Cardiovascular Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 61 Respiratory Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 62 CNS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 63 CNS Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 64 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 65 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 66 Pharma Contract Sales Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 67 Pharma Contract Sales Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 68 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 69 North America Pharma Contract Sales Market Attractiveness Index
Figure 70 North America Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 71 North America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 72 North America Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 73 North America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 74 North America Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 75 North America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 76 North America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 77 North America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 78 North America Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 79 North America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 80 North America Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 81 North America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 82 North America Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 83 U.S. Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 84 Canada Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 85 Europe Pharma Contract Sales Market Attractiveness Index
Figure 86 Europe Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 87 Europe Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 88 Europe Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 89 Europe Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 90 Europe Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 91 Europe Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 92 Europe Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 93 Europe Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 94 Europe Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 95 Europe Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 96 Europe Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 97 Europe Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 98 Europe Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 99 Germany Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 France Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 UK Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 Italy Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 103 Spain Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 Russia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 105 Rest of Europe Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 Asia Pacific Pharma Contract Sales Market Attractiveness Index
Figure 107 Asia Pacific Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 108 Asia Pacific Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 109 Asia Pacific Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 110 Asia Pacific Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 111 Asia Pacific Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 112 Asia Pacific Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 113 Asia Pacific Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 114 Asia Pacific Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 115 Asia Pacific Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 116 Asia Pacific Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 117 Asia Pacific Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 118 Asia Pacific Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 119 Asia Pacific Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 120 Japan Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 China Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 122 India Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 123 Australia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 South Korea Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 125 Rest of Asia Pacific Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 126 Latin America Pharma Contract Sales Market Attractiveness Index
Figure 127 Latin America Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 128 Latin America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 129 Latin America Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 130 Latin America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 131 Latin America Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 132 Latin America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 133 Latin America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 134 Latin America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 135 Latin America Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 136 Latin America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 137 Latin America Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 138 Latin America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 139 Latin America Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 140 Brazil Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 141 Mexico Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 142 Rest of Latin America Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 MEA Pharma Contract Sales Market Attractiveness Index
Figure 144 MEA Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 145 MEA Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 146 MEA Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 147 MEA Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 148 MEA Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 149 MEA Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 150 MEA Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 151 MEA Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 152 MEA Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 153 MEA Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 154 MEA Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 155 MEA Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 156 MEA Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 157 GCC Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 158 South Africa Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 159 Rest of MEA Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 160 Pharma Contract Sales Market: Company Share/Ranking, 2022
Figure 161 CMIC Holdings Co., Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 162 IQVIA Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 163 IQVIA Inc.: Regional Market Shares, 2022
Figure 164 Syneos Health: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 165 Syneos Health: Regional Market Shares, 2022
Figure 166 Inizio Group Limited: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 167 Inizio Group Limited: Regional Market Shares, 2022
Figure 168 Uniphar Group Plc: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 169 ICON plc: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 170 ICON plc: Regional Market Shares, 2022
Figure 171 PUBLICIS GROUPE: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 172 PUBLICIS GROUPE: Regional Market Shares, 2022
ページTOPに戻る
Summary
Report Details
The Pharma Contract Sales Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Global Players Consolidating CRO and CSO Operations to Offer End-to-end Services
Major industry players are integrating Contract Research Organization (CRO) and Contract Sales Organization (CSO) operations, resulting in significant benefits. Several prominent CRO providers have effectively combined their services with commercialization capabilities through mergers and acquisitions (M&A), enabling them to offer comprehensive solutions to clients across the drug development journey.
Notable instances of such strategic moves include INC Research’s acquisition and subsequent rebranding as Syneos, as well as Quintiles’ acquisition of IMS. Similarly, in January 2023, Publicis Groupe recently revealed their acquisition of Advertise BG, a prominent performance marketing agency in Bulgaria. This strategic move aims to enhance Publicis Groupe Bulgaria’s capabilities in digital transformation, bolstering their services in digital strategy, data analytics, social media management, and digital content production.
This trend towards consolidation and integration within the CRO and CSO landscape is expected to fuel the demand for contract sales services. The seamless integration of research, development, and commercialization services facilitates a more streamlined and efficient drug development process. Clients seeking a holistic and efficient approach are likely to increasingly turn to providers offering end-to-end solutions, further stimulating the demand for contract sales services.
Growing Demand for Pharma Contract Sales Services
In recent years, the pharmaceutical industry has witnessed a significant transformation marked by diversification and specialization. This evolution has led to an increased demand for pharma contract sales services worldwide. As pharmaceutical companies expand their product portfolios to encompass a broader range of therapeutic areas, they face the challenge of effectively promoting and distributing these diverse offerings.
Pharma contract sales services provide a strategic solution by offering specialized sales teams and tailored marketing strategies. These services allow pharmaceutical companies to access experienced professionals with deep industry knowledge and networks, enabling efficient market penetration for their varied product lines. Additionally, the cost-effectiveness and flexibility offered by contract sales services make them an attractive option for companies looking to optimize resource allocation.
Furthermore, globalization has expanded market reach, requiring companies to adapt to various regulatory environments and market dynamics. Pharma contract sales services facilitate this adaptation by providing local expertise and understanding of regional markets, ensuring compliance and effective engagement with healthcare professionals.
In conclusion, the diversification of the pharmaceutical industry has heightened the need for agile and specialized sales and marketing approaches. Pharma contract sales services have emerged as a crucial tool in meeting these evolving demands, ultimately enhancing the industry’s ability to effectively reach and serve diverse markets.
What Questions Should You Ask before Buying a Market Research Report?
• How is the Pharma Contract Sales market evolving?
• What is driving and restraining the Pharma Contract Sales market?
• How will each Pharma Contract Sales submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Pharma Contract Sales submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Pharma Contract Sales markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Pharma Contract Sales projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Pharma Contract Sales projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Pharma Contract Sales market?
• Where is the Pharma Contract Sales market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Pharma Contract Sales market today, and over the next 10 years:
• Our 304-page report provides 128 tables and 172 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Pharma Contract Sales market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Pharma Contract Sales prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Type
• Personal Promotion
– Promotional Sales Team
– Vacancy Management
– Health Care Professional
• Non-personal Promotion
– Contact Centre
– Tele-detailing
– Medical Call Centres
– Telesampling
– Online Services
• Co-promotion
– Marketing Research and Consulting
– Product Commercialization
– Territory Optimization and Alignment
– Brand Management
– Mature Product Line Support
– Rest All CSO Services
Therapeutics
• Oncology
• Immunology
• Diabetes
• Cardiovascular Disease
• Respiratory
• CNS
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Pharma Contract Sales Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies profiled in the report
• Amplity Health
• Apodi
• CMIC HOLDINGS Co., Ltd.
• Granard Pharmaceutical Sales & Marketing
• GTS Solution
• ICON plc
• Inizio Group Limited
• IQVIA Inc.
• MaBiCo
• Marvecs GmbH
• ONCALL, LLC
• PUBLICIS GROUPE
• QFR Solution
• Sales Partnerships, Inc.
• SOFIP
• Syneos Health
• Uniphar Group Plc
• Vanguard Pharma
Overall world revenue for Pharma Contract Sales Market, 2023 to 2033 in terms of value the market will surpass US$7,600 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Pharma Contract Sales Market, 2023 to 2033 report help you?
In summary, our 300+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Pharma Contract Sales Market, 2023 to 2033 Market, with forecasts for type and therapeutics each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 21 key national markets – See forecasts for the Pharma Contract Sales Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 18 of the major companies involved in the Pharma Contract Sales Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pharma Contract Sales Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Pharma Contract Sales Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Significance of Data in Pharma to Drive the Market Demand
3.2.1.2 Global Players Consolidating CRO and CSO Operations to Offer End-to-end Services
3.2.1.3 Transforming Pharma Sales: Technology and Outsourcing in the Pharmaceutical Services Industry
3.2.2 Market Restraining Factors
3.2.2.1 Quality Challenges in the Competitive Contract Pharma Services Market
3.2.2.2 Navigating Regulatory Hurdles and Timelines in Pharmaceutical Contract Manufacturing
3.2.3 Market Opportunities
3.2.3.1 Rising Opportunities for Pharmaceutical Expansion in Asian Markets
3.2.3.2 Diversification Trends in the Pharma Industry: Increasing Inorganic and Organic Activities to Create Market Opportunities
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Pharma Contract Sales Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Pharma Contract Sales Market Size Estimation and Forecast by Type
4.4 Personal Promotion
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Promotional Sales Team
4.4.3.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.4 Vacancy Management
4.4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.5 Health Care Professional
4.4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5 Non-personal Promotion
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5.3 Contact Centre
4.5.3.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.5.4 Tele-detailing
4.5.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.4.2 Market Share by Region, 2023 & 2033 (%)
4.5.5 Medical Call Centres
4.5.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.5.2 Market Share by Region, 2023 & 2033 (%)
4.5.6 Telesampling
4.5.6.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.6.2 Market Share by Region, 2023 & 2033 (%)
4.5.7 Online Services
4.5.7.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.7.2 Market Share by Region, 2023 & 2033 (%)
4.6 Co-promotion
4.6.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.6.3 Marketing Research and Consulting
4.6.3.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.3.2 Market Share by Region, 2023 & 2033 (%)
4.6.4 Product Commercialization
4.6.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.4.2 Market Share by Region, 2023 & 2033 (%)
4.6.5 Territory Optimization & Alignment
4.6.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.5.2 Market Share by Region, 2023 & 2033 (%)
4.6.6 Brand Management
4.6.6.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.6.2 Market Share by Region, 2023 & 2033 (%)
4.6.7 Mature Product Line Support
4.6.7.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.7.2 Market Share by Region, 2023 & 2033 (%)
4.6.8 Rest All CSO Services
4.6.8.1 Market Size by Region, 2023-2033 (US$ Million)
4.6.8.2 Market Share by Region, 2023 & 2033 (%)
5 Pharma Contract Sales Market Analysis by Therapeutics
5.1 Key Findings
5.2 Therapeutics Segment: Market Attractiveness Index
5.3 Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
5.4 Oncology
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Immunology
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Diabetes
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Cardiovascular Disease
5.7.1 Market Size by Region, 2023-2033 (US$ Million)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Respiratory
5.8.1 Market Size by Region, 2023-2033 (US$ Million)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 CNS
5.9.1 Market Size by Region, 2023-2033 (US$ Million)
5.9.2 Market Share by Region, 2023 & 2033 (%)
5.10 Others
5.10.1 Market Size by Region, 2023-2033 (US$ Million)
5.10.2 Market Share by Region, 2023 & 2033 (%)
6 Pharma Contract Sales Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Pharma Contract Sales Market Analysis
7.1 Key Findings
7.2 North America Pharma Contract Sales Market Attractiveness Index
7.3 North America Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
7.4 North America Pharma Contract Sales Market Size Estimation and Forecast by Country
7.5 North America Pharma Contract Sales Market Size Estimation and Forecast by Type
7.5.1 North America Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
7.5.2 North America Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
7.5.3 North America Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
7.6 North America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
7.7 U.S. Pharma Contract Sales Market Analysis
7.8 Canada Pharma Contract Sales Market Analysis
8 Europe Pharma Contract Sales Market Analysis
8.1 Key Findings
8.2 Europe Pharma Contract Sales Market Attractiveness Index
8.3 Europe Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
8.4 Europe Pharma Contract Sales Market Size Estimation and Forecast by Country
8.5 Europe Pharma Contract Sales Market Size Estimation and Forecast by Type
8.5.1 Europe Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
8.5.2 Europe Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
8.5.3 Europe Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
8.6 Europe Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
8.7 Germany Pharma Contract Sales Market Analysis
8.8 France Pharma Contract Sales Market Analysis
8.9 UK Pharma Contract Sales Market Analysis
8.10 Italy Pharma Contract Sales Market Analysis
8.11 Spain Pharma Contract Sales Market Analysis
8.12 Russia Pharma Contract Sales Market Analysis
8.13 Rest of Europe Pharma Contract Sales Market Analysis
9 Asia Pacific Pharma Contract Sales Market Analysis
9.1 Key Findings
9.2 Asia Pacific Pharma Contract Sales Market Attractiveness Index
9.3 Asia Pacific Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Country
9.5 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Type
9.5.1 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
9.5.2 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
9.5.3 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
9.6 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
9.7 Japan Pharma Contract Sales Market Analysis
9.8 China Pharma Contract Sales Market Analysis
9.9 India Pharma Contract Sales Market Analysis
9.10 Australia Pharma Contract Sales Market Analysis
9.11 South Korea Pharma Contract Sales Market Analysis
9.12 Rest of Asia Pacific Pharma Contract Sales Market Analysis
10 Latin America Pharma Contract Sales Market Analysis
10.1 Key Findings
10.2 Latin America Pharma Contract Sales Market Attractiveness Index
10.3 Latin America Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Country
10.5 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Type
10.5.1 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
10.5.2 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
10.5.3 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
10.6 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
10.7 Brazil Pharma Contract Sales Market Analysis
10.8 Mexico Pharma Contract Sales Market Analysis
10.9 Rest of Latin America Pharma Contract Sales Market Analysis
11 MEA Pharma Contract Sales Market Analysis
11.1 Key Findings
11.2 MEA Pharma Contract Sales Market Attractiveness Index
11.3 MEA Pharma Contract Sales Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 MEA Pharma Contract Sales Market Size Estimation and Forecast by Country
11.5 MEA Pharma Contract Sales Market Size Estimation and Forecast by Type
11.5.1 MEA Pharma Contract Sales Market Size Estimation and Forecast by Personal Promotion
11.5.2 MEA Pharma Contract Sales Market Size Estimation and Forecast by Non-personal Promotion
11.5.3 MEA Pharma Contract Sales Market Size Estimation and Forecast by Co-promotion
11.6 MEA Pharma Contract Sales Market Size Estimation and Forecast by Therapeutics
11.7 GCC Pharma Contract Sales Market Analysis
11.8 South Africa Pharma Contract Sales Market Analysis
11.9 Rest of MEA Pharma Contract Sales Market Analysis
12 Company Profiles
12.1 Competitive Landscape, 2022
12.2 Strategic Outlook
12.3 CMIC HOLDINGS Co., LTD.
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Net Revenue, 2017-2022
12.3.4 Solution Benchmarking
12.3.5 Strategic Outlook
12.4 IQVIA Inc.
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2017-2022
12.4.3.2 Regional Market Shares, 2022
12.4.4 Solution Benchmarking
12.4.5 Strategic Outlook
12.5 Syneos Health
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2017-2022
12.5.3.2 Regional Market Shares, 2022
12.5.4 Solution Benchmarking
12.5.5 Strategic Outlook
12.6 Inizio Group Limited
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2017-2022
12.6.3.2 Regional Market Shares, 2022
12.6.4 Solution Benchmarking
12.6.5 Strategic Outlook
12.7 Uniphar Group Plc
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2017-2022
12.7.4 Solution Benchmarking
12.7.5 Strategic Outlook
12.8 ICON plc
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2017-2022
12.8.3.2 Regional Market Shares, 2022
12.8.4 Solution Benchmarking
12.9 Amplity Health
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Solution Benchmarking
12.9.4 Strategic Outlook
12.10 Apodi
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Solution Benchmarking
12.11 Marvecs GmbH
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Solution Benchmarking
12.11.4 Strategic Outlook
12.12 ONCALL, LLC.
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Solution Benchmarking
12.13 PUBLICIS GROUPE
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Financial Analysis
12.13.3.1 Net Revenue, 2017-2022
12.13.3.2 Regional Market Shares, 2022
12.13.4 Solution Benchmarking
12.13.5 Strategic Outlook
12.14 SOFIP
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Solution Benchmarking
12.15 Granard Pharmaceutical Sales & Marketing
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Solution Benchmarking
12.16 Vanguard Pharma
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Solution Benchmarking
12.17 GTS Solution
12.17.1 Company Snapshot
12.17.2 Company Overview
12.17.3 Solution Benchmarking
12.18 MaBiCo
12.18.1 Company Snapshot
12.18.2 Company Overview
12.18.3 Solution Benchmarking
12.19 Sales Partnerships, Inc.
12.19.1 Company Snapshot
12.19.2 Company Overview
12.19.3 Solution Benchmarking
12.20 QFR Solution
12.20.1 Company Snapshot
12.20.2 Company Overview
12.20.3 Solution Benchmarking
13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 Pharma Contract Sales Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Promotional Sales Team Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Vacancy Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Health Care Professional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Non-personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Contact Centre Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Tele-detailing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Medical Call Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Telesampling Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Online Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Co-promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Marketing Research and Consulting Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Product Commercialization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Territory Optimization & Alignment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Brand Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Mature Product Line Support Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Rest All CSO Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 25 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Diabetes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 CNS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Pharma Contract Sales Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 North America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 North America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 North America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 North America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 North America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 38 North America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 39 U.S. Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Canada Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Europe Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 42 Europe Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Europe Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Europe Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Europe Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 46 Europe Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 47 Germany Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 France Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 UK Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Italy Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Spain Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Russia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Rest of Europe Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Asia Pacific Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Asia Pacific Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Asia Pacific Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Asia Pacific Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Asia Pacific Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 59 Asia Pacific Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 60 Japan Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 China Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 India Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Australia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 South Korea Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Rest of Asia Pacific Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Latin America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Latin America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Latin America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 Latin America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 Latin America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 71 Latin America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 72 Brazil Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 Mexico Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 Rest of Latin America Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 MEA Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 MEA Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 MEA Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 78 MEA Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 79 MEA Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 80 MEA Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 81 GCC Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 82 South Africa Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 83 Rest of MEA Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 84 Strategic Outlook
Table 85 CMIC HOLDINGS Co., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 CMIC Holdings Co., Ltd.: Solution Benchmarking
Table 87 CMIC Holdings Co., Ltd.: Strategic Outlook
Table 88 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 IQVIA Inc.: Solution Benchmarking
Table 90 IQVIA Inc.: Strategic Outlook
Table 91 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Syneos Health: Solution Benchmarking
Table 93 Syneos Health: Strategic Outlook
Table 94 Inizio Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Inizio Group Limited: Solution Benchmarking
Table 96 Inizio Group Limited: Strategic Outlook
Table 97 Uniphar Group Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Uniphar Group Plc: Solution Benchmarking
Table 99 Uniphar Group Plc: Strategic Outlook
Table 100 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 ICON plc: Solution Benchmarking
Table 102 Amplity Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Amplity Health: Solution Benchmarking
Table 104 Amplity Health: Strategic Outlook
Table 105 Apodi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Apodi: Solution Benchmarking
Table 107 Marvecs GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Marvecs GmbH: Solution Benchmarking
Table 109 Marvecs GmbH: Strategic Outlook
Table 110 ONCALL, LLC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 ONCALL, LLC.: Solution Benchmarking
Table 112 PUBLICIS GROUPE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 PUBLICIS GROUPE: Solution Benchmarking
Table 114 PUBLICIS GROUPE: Strategic Outlook
Table 115 SOFIP: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 SOFIP: Solution Benchmarking
Table 117 Granard Pharmaceutical Sales & Marketing: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Granard Pharmaceutical Sales & Marketing: Solution Benchmarking
Table 119 Vanguard Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Vanguard Pharma: Solution Benchmarking
Table 121 GTS Solution: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 GTS Solution: Solution Benchmarking
Table 123 MaBiCo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 MaBiCo: Solution Benchmarking
Table 125 Sales Partnerships, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Sales Partnerships, Inc.: Solution Benchmarking
Table 127 QFR Solution: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 QFR Solution: Solution Benchmarking
List of Figures
Figure 1 Pharma Contract Sales Market Segmentation
Figure 2 Pharma Contract Sales Market by Type: Market Attractiveness Index
Figure 3 Pharma Contract Sales Market by Therapeutics: Market Attractiveness Index
Figure 4 Pharma Contract Sales Market Attractiveness Index by Region
Figure 5 Pharma Contract Sales Market: Market Dynamics
Figure 6 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 7 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 8 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 9 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 10 Pharma Contract Sales Market: Porter’s Five Forces Analysis
Figure 11 Pharma Contract Sales Market: PEST Analysis
Figure 12 Pharma Contract Sales Market by Type: Market Attractiveness Index
Figure 13 Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 14 Pharma Contract Sales Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 15 Personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 16 Personal Promotion Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Promotional Sales Team Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Promotional Sales Team Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Vacancy Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Vacancy Management Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Health Care Professional Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 22 Health Care Professional Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Non-personal Promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Non-personal Promotion Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Contact Centre Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Contact Centre Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Tele-detailing Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Tele-detailing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Medical Call Centres Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 30 Medical Call Centres Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Telesampling Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 32 Telesampling Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Online Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 34 Online Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Co-promotion Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 36 Co-promotion Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Marketing Research and Consulting Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Marketing Research and Consulting Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Product Commercialization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Product Commercialization Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Territory Optimization & Alignment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Territory Optimization & Alignment Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Brand Management Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Brand Management Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Mature Product Line Support Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Mature Product Line Support Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Rest All CSO Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Rest All CSO Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Pharma Contract Sales Market by Therapeutics: Market Attractiveness Index
Figure 50 Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 51 Pharma Contract Sales Market Share Forecast by Therapeutics, 2023, 2028, 2033 (%)
Figure 52 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 53 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 55 Immunology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Diabetes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 57 Diabetes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 Cardiovascular Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Respiratory Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 61 Respiratory Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 62 CNS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 63 CNS Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 64 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 65 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 66 Pharma Contract Sales Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 67 Pharma Contract Sales Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 68 Pharma Contract Sales Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 69 North America Pharma Contract Sales Market Attractiveness Index
Figure 70 North America Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 71 North America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 72 North America Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 73 North America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 74 North America Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 75 North America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 76 North America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 77 North America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 78 North America Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 79 North America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 80 North America Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 81 North America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 82 North America Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 83 U.S. Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 84 Canada Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 85 Europe Pharma Contract Sales Market Attractiveness Index
Figure 86 Europe Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 87 Europe Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 88 Europe Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 89 Europe Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 90 Europe Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 91 Europe Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 92 Europe Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 93 Europe Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 94 Europe Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 95 Europe Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 96 Europe Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 97 Europe Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 98 Europe Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 99 Germany Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 France Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 UK Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 Italy Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 103 Spain Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 Russia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 105 Rest of Europe Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 Asia Pacific Pharma Contract Sales Market Attractiveness Index
Figure 107 Asia Pacific Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 108 Asia Pacific Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 109 Asia Pacific Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 110 Asia Pacific Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 111 Asia Pacific Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 112 Asia Pacific Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 113 Asia Pacific Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 114 Asia Pacific Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 115 Asia Pacific Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 116 Asia Pacific Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 117 Asia Pacific Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 118 Asia Pacific Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 119 Asia Pacific Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 120 Japan Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 China Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 122 India Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 123 Australia Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 South Korea Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 125 Rest of Asia Pacific Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 126 Latin America Pharma Contract Sales Market Attractiveness Index
Figure 127 Latin America Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 128 Latin America Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 129 Latin America Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 130 Latin America Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 131 Latin America Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 132 Latin America Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 133 Latin America Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 134 Latin America Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 135 Latin America Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 136 Latin America Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 137 Latin America Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 138 Latin America Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 139 Latin America Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 140 Brazil Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 141 Mexico Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 142 Rest of Latin America Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 MEA Pharma Contract Sales Market Attractiveness Index
Figure 144 MEA Pharma Contract Sales Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 145 MEA Pharma Contract Sales Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 146 MEA Pharma Contract Sales Market Share Forecast by Country, 2023 & 2033 (%)
Figure 147 MEA Pharma Contract Sales Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 148 MEA Pharma Contract Sales Market Share Forecast by Type, 2023 & 2033 (%)
Figure 149 MEA Pharma Contract Sales Market Forecast by Personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 150 MEA Pharma Contract Sales Market Share Forecast by Personal Promotion, 2023 & 2033 (%)
Figure 151 MEA Pharma Contract Sales Market Forecast by Non-personal Promotion, 2023-2033 (US$ Million, AGR %)
Figure 152 MEA Pharma Contract Sales Market Share Forecast by Non-personal Promotion, 2023 & 2033 (%)
Figure 153 MEA Pharma Contract Sales Market Forecast by Co-promotion, 2023-2033 (US$ Million, AGR %)
Figure 154 MEA Pharma Contract Sales Market Share Forecast by Co-promotion, 2023 & 2033 (%)
Figure 155 MEA Pharma Contract Sales Market Forecast by Therapeutics, 2023-2033 (US$ Million, AGR %)
Figure 156 MEA Pharma Contract Sales Market Share Forecast by Therapeutics, 2023 & 2033 (%)
Figure 157 GCC Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 158 South Africa Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 159 Rest of MEA Pharma Contract Sales Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 160 Pharma Contract Sales Market: Company Share/Ranking, 2022
Figure 161 CMIC Holdings Co., Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 162 IQVIA Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 163 IQVIA Inc.: Regional Market Shares, 2022
Figure 164 Syneos Health: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 165 Syneos Health: Regional Market Shares, 2022
Figure 166 Inizio Group Limited: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 167 Inizio Group Limited: Regional Market Shares, 2022
Figure 168 Uniphar Group Plc: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 169 ICON plc: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 170 ICON plc: Regional Market Shares, 2022
Figure 171 PUBLICIS GROUPE: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 172 PUBLICIS GROUPE: Regional Market Shares, 2022
ページTOPに戻る
本レポートと同分野（医療/ヘルスケア）の最新刊レポート
Visiongain社の医薬・化学品分野での最新刊レポート
本レポートと同じKEY WORD（cardiovascular）の最新刊レポート
-
Digital Denture Market by Type (Tubes, Tips, Restractors, Cannulae), Usability (Disposable, Reusable), Application (General Surgery, Neurosurgery, Orthopedic, Cardiovascular, Dental), End User, and Region - Global Forecast to 2029
-
心血管カテーテルの世界市場 2024-2028
-
自己細胞療法市場 - 世界の産業規模、シェア、動向、機会、予測、供給源別（骨髄、表皮、間葉系幹細胞、造血幹細胞、軟骨細胞、その他）、用途別（がん、神経変性疾患、心血管疾患、自己免疫疾患、整形外科、創傷治癒、その他）、エンドユーザー別（病院＆クリニック、外来センター、その他）、地域別、競合別、2019-2029F
-
合成幹細胞市場 - 世界の産業規模、シェア、動向、機会、予測、用途別（心血管疾患、神経疾患、その他の用途（癌、創傷・傷害、筋骨格系疾患、血液疾患））、地域別、競合別セグメント、2019-2029F
-
トルコの医療ツーリズム市場：タイプ別（インバウンド・アウトバウンド）、治療タイプ別（美容治療、植毛治療、歯科治療、心臓血管治療、婦人科治療、整形外科治療、その他）、地域別、市場競争、予測、機会：2019-2029F
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
